$TNXP SEC Filings

Filed On	Filing
15 Oct 2026	8-K: Results of Operations and Financial Condition; Other Events Tonix Pharmaceuticals Holding Corp. (the “Company”) is disclosing selected preliminary operating results for the quarter ended September 30, 2026.
02 Oct 2026	8-K: Other Events On October 1, 2026, Tonix Pharmaceuticals Holding Corp. (the “Company”) received a notice (the “Notice”) from Dr. Reddy’s Laboratories Ltd. and Dr. Reddy’s Laboratories, Inc. (collectively, “DRL”) stating that DRL filed an Abbreviated Ne...
22 Sep 2026	8-K: Other Events New agreement, effective immediately, adds approximately 21 million Medicare lives (38% of approximately 55 million Medicare lives in the U.S.)
08 Sep 2026	Form 3: Englese Thomas, Chief Commercial Officer Holds 694 shares of Common Stock, $0.001 par value per share
08 Sep 2026	8-K: Other Events Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
31 Aug 2026	Form 4: Lederman Seth, Director Bought 2,000 shares ($27.6K)
24 Aug 2026	Form 4: Bagger Richard H, Director Bought 1,000 shares ($12.6K)
18 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	SCHEDULE 13G
10 Aug 2026	QUARTERLY REPORT
10 Aug 2026	8-K: Results of Operations and Financial Condition
03 Aug 2026	8-K: Regulation FD Disclosure; Other Events
21 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
13 Jul 2026	8-K: Regulation FD Disclosure; Other Events
09 Jul 2026	Form 4: Saenger Bradley, Chief Financial Officer Acquired 1,453 shares (Other Transaction) ($15.9K)
01 Jul 2026	S-8
29 Jun 2026	8-K: Regulation FD Disclosure; Other Events
15 Jun 2026	SCHEDULE 13G
15 Jun 2026	Form 4: Taylor Carolyn E., Director Bought 1,415 shares ($14.9K)

Comments